Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer. (2018)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2017.08.009
PubMed Identifier: 28866255
Publication URI: http://europepmc.org/abstract/MED/28866255
Type: Journal Article/Review
Volume: 73
Parent Publication: European urology
Issue: 5
ISSN: 0302-2838